Progenics Pharma (PGNX)

4.60 +0.18 (4.07%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (5/2/18 *Est.)

Latest Headlines

Form 10-K PROGENICS PHARMACEUTICAL For: Dec 31 March 15, 2019 6:25 AM - SEC Filing Progenics Pharmaceuticals (PGNX) AZEDRA Revenues Likely to Start in 2Q, Needham & Company Says; PT to $10 March 14, 2019 1:28 PM - StreetInsider Form 8-K PROGENICS PHARMACEUTICAL For: Mar 14 March 14, 2019 7:58 AM - SEC Filing Progenics Pharmaceuticals Announces Fourth Quarter and Full-Year 2018 Financial Results and Business Update March 14, 2019 7:45 AM - Globe NewsWire Progenics Pharmaceuticals Announces Fourth Quarter and Full-Year 2018 Financial Results and Business Update March 14, 2019 7:45 AM - StreetInsider Progenics Asserts Ownership of PSMA-617 Intellectual Property, Including Composition of Matter Patent March 14, 2019 7:40 AM - Globe NewsWire Progenics Asserts Ownership of PSMA-617 Intellectual Property, Including Composition of Matter Patent March 14, 2019 7:40 AM - StreetInsider Progenics Pharmaceuticals Announces Presentation of Safety Data for AZEDRA® (iobenguane I 131) at the 2019 Endocrine Society (ENDO) Annual Meeting March 11, 2019 8:30 AM - Globe NewsWire Progenics Pharmaceuticals Announces Presentation of Safety Data for AZEDRA® (iobenguane I 131) at the 2019 Endocrine Society (ENDO) Annual Meeting March 11, 2019 8:30 AM - Globe NewsWire Progenics Pharmaceuticals Announces Presentation of Safety Data for AZEDRA® (iobenguane I 131) at the 2019 Endocrine Society (ENDO) Annual Meeting March 11, 2019 8:30 AM - StreetInsider Progenics Pharmaceuticals Sets Fourth Quarter and Full-Year 2018 Financial Results and Business Update Call for March 14 March 7, 2019 8:30 AM - Globe NewsWire Progenics Pharmaceuticals Sets Fourth Quarter and Full-Year 2018 Financial Results and Business Update Call for March 14 March 7, 2019 8:30 AM - StreetInsider Form 4 PROGENICS PHARMACEUTICAL For: Mar 01 Filed by: Osorio Benedict March 5, 2019 4:38 PM - SEC Filing Form 4 PROGENICS PHARMACEUTICAL For: Mar 01 Filed by: Fabbio Patrick March 5, 2019 3:54 PM - SEC Filing Form 4 PROGENICS PHARMACEUTICAL For: Mar 01 Filed by: Tenbarge Bryce March 5, 2019 3:53 PM - SEC Filing Form 4 PROGENICS PHARMACEUTICAL For: Mar 01 Filed by: Wong Vivien March 5, 2019 3:51 PM - SEC Filing Form 4 PROGENICS PHARMACEUTICAL For: Mar 01 Filed by: Baker Mark Robert March 5, 2019 3:50 PM - SEC Filing Form SC 13G/A PROGENICS PHARMACEUTICAL Filed by: ARMISTICE CAPITAL, LLC February 14, 2019 3:11 PM - SEC Filing Form SC 13G PROGENICS PHARMACEUTICAL Filed by: STATE STREET CORP February 14, 2019 10:35 AM - SEC Filing Form 8-K PROGENICS PHARMACEUTICAL For: Feb 11 February 11, 2019 4:04 PM - SEC Filing Form SC 13G/A PROGENICS PHARMACEUTICAL Filed by: VANGUARD GROUP INC February 11, 2019 9:55 AM - SEC Filing Progenics Pharma (PGNX) Acquires AZEDRA Radiopharmaceutical Manufacturing Facility for $8M February 11, 2019 8:31 AM - StreetInsider Progenics Acquires AZEDRA® (iobenguane I 131) Radiopharmaceutical Manufacturing Facility February 11, 2019 8:30 AM - Globe NewsWire Progenics Acquires AZEDRA® (iobenguane I 131) Radiopharmaceutical Manufacturing Facility February 11, 2019 8:30 AM - StreetInsider Form 4 PROGENICS PHARMACEUTICAL For: Feb 01 Filed by: Das Asha February 5, 2019 11:11 AM - SEC Filing Form SC 13G/A PROGENICS PHARMACEUTICAL Filed by: BlackRock Inc. January 31, 2019 2:10 PM - SEC Filing Market Trends Toward New Normal in Agilent Technologies, Xilinx, Interpublic Group of Companies, Progenics Pharmaceuticals, Flexsteel Industries, and USA Truck — Emerging Consolidated Expectations, January 22, 2019 7:45 AM - Globe NewsWire Form SC 13G/A PROGENICS PHARMACEUTICAL Filed by: EAGLE ASSET MANAGEMENT INC January 16, 2019 1:52 PM - SEC Filing Form 3 PROGENICS PHARMACEUTICAL For: Jan 02 Filed by: Das Asha January 11, 2019 9:52 AM - SEC Filing Form 8-K PROGENICS PHARMACEUTICAL For: Jan 04 January 4, 2019 4:36 PM - SEC Filing Pre-Open Stock Movers 01/03: (OHRP) (CELG) (DBVT) Higher; (AAPL) (LITE) (BMY) Lower (more...) January 3, 2019 9:22 AM - StreetInsider Progenics Pharma (PGNX), Curium Report European Collaboration for Prostate Cancer Imaging Agent PyL January 3, 2019 6:00 AM - StreetInsider Curium and Progenics Announce European Collaboration for Prostate Cancer Imaging Agent PyL™ January 3, 2019 2:30 AM - Globe NewsWire Curium and Progenics Announce European Collaboration for Prostate Cancer Imaging Agent PyL™ January 3, 2019 2:30 AM - StreetInsider Progenics and Curium Announce European Collaboration for Prostate Cancer Imaging Agent PyL™ January 3, 2019 1:30 AM - Globe NewsWire Progenics and Curium Announce European Collaboration for Prostate Cancer Imaging Agent PyL™ January 3, 2019 1:30 AM - StreetInsider After-Hours Movers 01/02: (GNMX) (LITE) (AAPL) Lower (more...) January 2, 2019 6:04 PM - StreetInsider Point72 Asset Management, L.P. Shows New 5.7% Stake in Progenics Pharmaceuticals, Inc. (PGNX) January 2, 2019 5:29 PM - StreetInsider Form SC 13G PROGENICS PHARMACEUTICAL Filed by: Point72 Asset Management, L.P. January 2, 2019 4:35 PM - SEC Filing Progenics Pharma (PGNX) Names Asha Das as Chief Medical Officer January 2, 2019 8:32 AM - StreetInsider Progenics Pharmaceuticals Expands Leadership Team with Appointment of Asha Das, M.D. as Chief Medical Officer  January 2, 2019 8:30 AM - Globe NewsWire Progenics Pharmaceuticals Expands Leadership Team with Appointment of Asha Das, M.D. as Chief Medical Officer  January 2, 2019 8:30 AM - StreetInsider Full Article List